The purpose of discussing this case is to evaluate the activity of cyclin-dependent kinase 4 (CDK-4) and murine double minute 2 (MDM2) expression as a molecular morphology marker of bone tumor formation versus other common immunohistochemistry (IHC) reactions. The gene discussed is CDK4; the disease is bone neoplasm.